Drugmaker Questioned for Nearly Tripling Price of Potential COVID-19 Drug
Insurance Journal - May 05, 2020
The chair of a House of Representatives committee and a fellow Democratic committee member on Monday urged Jaguar Health Inc. to reverse recent price hikes of a drug that could be used to treat side effects in COVID-19 patients and …...
Recommended Articles
Posted: Oct 31, 2025
The wreckage caused by Hurricane Melissa in Jamaica is expected to cost insurers $1 billion to $3 bi...
Posted: Oct 31, 2025
Philadelphia Insurance Companies announced the acquisition of the Collector Vehicle Division from Ig...
Posted: Oct 31, 2025
New attributes—electrical panel location, roof life stage, and plumbing materials—enhance underwriti...